Related references
Note: Only part of the references are listed.Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients
Feng Gao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade
Herbert Tilg et al.
HEPATOLOGY (2021)
Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
Ivan Lopez-Mendez et al.
ANNALS OF HEPATOLOGY (2021)
Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis
Lu Pan et al.
DIGESTIVE AND LIVER DISEASE (2021)
Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome: a retrospective case-control study
Mahmud Mahamid et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)
Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points
Marcos F. Fondevila et al.
JOURNAL OF HEPATOLOGY (2021)
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel
Cecilia Napodano et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)
SARS-CoV-2 infection in patients with a normal or abnormal liver
Giuseppe Cabibbo et al.
JOURNAL OF VIRAL HEPATITIS (2021)
Does MAFLD really increase the severity of COVID-19?
Jonny Karunia Fajar et al.
DIGESTIVE AND LIVER DISEASE (2021)
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19
Alejandro Campos-Murguia et al.
DIGESTIVE AND LIVER DISEASE (2021)
NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues
Kamra Mushtaq et al.
JOURNAL OF HEPATOLOGY (2021)
COVID-19 and liver disease: mechanistic and clinical perspectives
Thomas Marjot et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
Feng Gao et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Metabolic Associated Fatty Liver Disease Is Associated With an Increased Risk of Severe COVID-19: A Systematic Review With Meta-Analysis
Peter Jeno Hegyi et al.
FRONTIERS IN MEDICINE (2021)
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study
Jitao Wang et al.
JOURNAL OF HEPATOLOGY (2021)
Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
Isabela Macedo Lopes Vasques-Monteiro et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Association of metabolic-associated fatty liver disease and risk of severe coronavirus disease 2019 illness
Marianne Linley Sy-Janairo et al.
JGH OPEN (2021)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Evidence for Gastrointestinal Infection of SARS-CoV-2
Fei Xiao et al.
GASTROENTEROLOGY (2020)
The outbreak of COVID-19: An overview
Yi-Chi Wu et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study
Lei Pan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
Giovanni Targher et al.
GUT (2020)
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
Xi Jin et al.
GUT (2020)
Pulmonary pathology of early-phase COVID-19 pneumonia in a patient with a benign lung lesion
Zhi Zeng et al.
HISTOPATHOLOGY (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19
Yijin Wang et al.
JOURNAL OF HEPATOLOGY (2020)
No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease
Louise Biquard et al.
JOURNAL OF HEPATOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Lack of genetic evidence that fatty liver disease predisposes to COVID-19
Luca Valenti et al.
JOURNAL OF HEPATOLOGY (2020)
Liver tests abnormalities in COVID-19: trick or treat?
Edoardo Vespa et al.
JOURNAL OF HEPATOLOGY (2020)
Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
Yu-Jie Zhou et al.
JOURNAL OF HEPATOLOGY (2020)
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
Dong Ji et al.
JOURNAL OF HEPATOLOGY (2020)
Macrophages in metabolic associated fatty liver disease
Jawaher Alharthi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Potential implications of COVID-19 in non-alcoholic fatty liver disease
Grietje H. Prins et al.
LIVER INTERNATIONAL (2020)
COVID-19 and liver disease
Jian Sun et al.
LIVER INTERNATIONAL (2020)
Liver injury during highly pathogenic human coronavirus infections
Ling Xu et al.
LIVER INTERNATIONAL (2020)
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Meng-Yuan Li et al.
INFECTIOUS DISEASES OF POVERTY (2020)
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
Paula Iruzubieta et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Endocrine and metabolic link to coronavirus infection
Stefan R. Bornstein et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
From NAFLD to MAFLD: when pathophysiology succeeds
Herbert Tilg et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Mild or Moderate Covid-19
Rajesh T. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning
Yehuda Shoenfeld
AUTOIMMUNITY REVIEWS (2020)
COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandemics
Piero Portincasa et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella
Geoffroy Mery et al.
FRONTIERS IN IMMUNOLOGY (2020)
COVID-19 and the liver
Dinesh Jothimani et al.
JOURNAL OF HEPATOLOGY (2020)
Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience
Nikroo Hashemi et al.
LIVER INTERNATIONAL (2020)
Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations
Aurelio Sonzogni et al.
LIVER INTERNATIONAL (2020)
Metabolic-associated fatty liver disease is associated with severity of COVID-19
Yu-Jie Zhou et al.
LIVER INTERNATIONAL (2020)
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
Kenneth I. Zheng et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data
Stephen M. Lagana et al.
MODERN PATHOLOGY (2020)
New-Onset Diabetes in Covid-19
Francesco Rubino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Gut microbiota and Covid-19-possible link and implications
Debojyoti Dhar et al.
VIRUS RESEARCH (2020)
MAFLD in COVID-19 patients: an insidious enemy
Paola Dongiovanni et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2020)
In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19
Roberta Forlano et al.
PLOS ONE (2020)
Etiology and management of liver injury in patients with COVID-19
Rui-Xu Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Clinical Features of Patients With COVID-19 With Nonalcoholic Fatty Liver Disease
Rui Huang et al.
HEPATOLOGY COMMUNICATIONS (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19
Praveen Sharma et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease
Jie Li et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2020)
Role of Human Macrophage Polarization in Inflammation during Infectious Diseases
Chiraz Atri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota
Maria L. Balmer et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Changes in macrophage phenotype as the immune response evolves
Julia Lichtnekert et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet
Manisha Gupte et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Share Paper
